Inogen | INGN - Operating Expenses


Inogen reported $49.14M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 140.72M 2.71M Mar/2026
Baxter International USD 6.04B 2.85B Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Boston Scientific USD 4.15B 107M Mar/2026
Chart Industries USD 832.2M 122.3M Mar/2026
Cooper Companies USD 1.11B 301.2M Mar/2026
Dexcom USD 936.6M 0 Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Globus Medical USD 595.85M 49.26M Mar/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 639.7M 2.2M Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Orthofix International USD 213.79M 12.36M Dec/2025
Philips EUR 3.6B 775M Mar/2026
ResMed USD 925.74M 525K Mar/2026
Steris USD 1.27B 51.5M Mar/2026
Stryker USD 4.92B 284M Mar/2026
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.08B 2.55B Mar/2026
X T L Biopharmaceuticals USD 1.1M 175K Dec/2024
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026